Hyperbaric oxygen therapy: a possible choice for patients with resistant thin endometrium during frozen embryo transfer treatments. | Canada Hyperbarics Skip to main content
Prospective Study Reproductive biology and endocrinology : RB&E 2023

Hyperbaric oxygen therapy: a possible choice for patients with resistant thin endometrium during frozen embryo transfer treatments.

Chen J, Huang F, Fu J, Zhao J, Li J, Peng Z, et al. — Reproductive biology and endocrinology : RB&E, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a prospective pre-post cohort study to investigate the impact of hyperbaric oxygen therapy (HBOT) on endometrial growth and pregnancy outcomes in patients with resistant thin endometrium undergoing frozen embryo transfer (FET).

What They Found

The provided abstract did not include the specific findings regarding endometrial thickness or pregnancy outcomes after hyperbaric oxygen therapy. Therefore, numerical results from this study cannot be reported here.

Canadian Relevance

This study was not conducted in Canada and has no direct Canadian connection.

Study Limitations

A limitation of this study is the voluntary assignment of patients to treatment groups, which could introduce selection bias despite propensity score matching.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Prospective Study
Category Uncategorised
Source Pubmed
PubMed ID 37658414
Year Published 2023
Journal Reproductive biology and endocrinology : RB&E
MeSH Terms Female; Pregnancy; Humans; Hyperbaric Oxygenation; Cohort Studies; Prospective Studies; Endometrium; Embryo Transfer

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology